GO:0016032 | viral process | 9.39e-04 | 1.00e+00 | 3.053 | 4 | 30 | 428 |
GO:0004832 | valine-tRNA ligase activity | 1.13e-03 | 1.00e+00 | 9.794 | 1 | 1 | 1 |
GO:0061383 | trabecula morphogenesis | 1.13e-03 | 1.00e+00 | 9.794 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.13e-03 | 1.00e+00 | 9.794 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.13e-03 | 1.00e+00 | 9.794 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.13e-03 | 1.00e+00 | 9.794 | 1 | 1 | 1 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.48e-03 | 1.00e+00 | 5.094 | 2 | 8 | 52 |
GO:0010467 | gene expression | 2.16e-03 | 1.00e+00 | 2.731 | 4 | 49 | 535 |
GO:0033688 | regulation of osteoblast proliferation | 2.25e-03 | 1.00e+00 | 8.794 | 1 | 1 | 2 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 2.25e-03 | 1.00e+00 | 8.794 | 1 | 1 | 2 |
GO:0001649 | osteoblast differentiation | 2.98e-03 | 1.00e+00 | 4.585 | 2 | 5 | 74 |
GO:0070006 | metalloaminopeptidase activity | 3.38e-03 | 1.00e+00 | 8.209 | 1 | 1 | 3 |
GO:0036089 | cleavage furrow formation | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 4 |
GO:0010815 | bradykinin catabolic process | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 4 |
GO:0070934 | CRD-mediated mRNA stabilization | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 2 | 5 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 5 |
GO:0043931 | ossification involved in bone maturation | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 5 |
GO:0005672 | transcription factor TFIIA complex | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 5.62e-03 | 1.00e+00 | 7.472 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 3 | 6 |
GO:0043297 | apical junction assembly | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 2 | 6 |
GO:0035615 | clathrin adaptor activity | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 1 | 7 |
GO:0000398 | mRNA splicing, via spliceosome | 8.68e-03 | 1.00e+00 | 3.794 | 2 | 15 | 128 |
GO:0090307 | spindle assembly involved in mitosis | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 2 | 8 |
GO:0006450 | regulation of translational fidelity | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 4 | 8 |
GO:0043296 | apical junction complex | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 1 | 8 |
GO:0030122 | AP-2 adaptor complex | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 9 |
GO:0030100 | regulation of endocytosis | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 9 |
GO:0048268 | clathrin coat assembly | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 2 | 9 |
GO:0072583 | clathrin-mediated endocytosis | 1.01e-02 | 1.00e+00 | 6.624 | 1 | 1 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 1 | 10 |
GO:0050919 | negative chemotaxis | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 4 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.23e-02 | 1.00e+00 | 6.335 | 1 | 4 | 11 |
GO:0005654 | nucleoplasm | 1.27e-02 | 1.00e+00 | 2.019 | 4 | 68 | 876 |
GO:0017025 | TBP-class protein binding | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 12 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.35e-02 | 1.00e+00 | 3.463 | 2 | 18 | 161 |
GO:0008380 | RNA splicing | 1.41e-02 | 1.00e+00 | 3.428 | 2 | 21 | 165 |
GO:0050772 | positive regulation of axonogenesis | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 2 | 13 |
GO:0050770 | regulation of axonogenesis | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 3 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 3 | 13 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 3 | 14 |
GO:0050771 | negative regulation of axonogenesis | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 2 | 14 |
GO:0004177 | aminopeptidase activity | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 3 | 14 |
GO:0000188 | inactivation of MAPK activity | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 1 | 15 |
GO:0032467 | positive regulation of cytokinesis | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 16 |
GO:0017022 | myosin binding | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 2 | 16 |
GO:0003899 | DNA-directed RNA polymerase activity | 2.01e-02 | 1.00e+00 | 5.624 | 1 | 3 | 18 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 2.01e-02 | 1.00e+00 | 3.157 | 2 | 8 | 199 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 1 | 19 |
GO:0071897 | DNA biosynthetic process | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 2 | 20 |
GO:0030054 | cell junction | 2.39e-02 | 1.00e+00 | 3.026 | 2 | 5 | 218 |
GO:0050690 | regulation of defense response to virus by virus | 2.45e-02 | 1.00e+00 | 5.335 | 1 | 1 | 22 |
GO:0001103 | RNA polymerase II repressing transcription factor binding | 2.56e-02 | 1.00e+00 | 5.270 | 1 | 2 | 23 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 2.56e-02 | 1.00e+00 | 5.270 | 1 | 1 | 23 |
GO:0006370 | 7-methylguanosine mRNA capping | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 6 | 24 |
GO:0007411 | axon guidance | 2.79e-02 | 1.00e+00 | 2.905 | 2 | 8 | 237 |
GO:0030145 | manganese ion binding | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 3 | 26 |
GO:0051496 | positive regulation of stress fiber assembly | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 2 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.00e-02 | 1.00e+00 | 5.039 | 1 | 4 | 27 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 3.11e-02 | 1.00e+00 | 4.987 | 1 | 2 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 3.22e-02 | 1.00e+00 | 4.936 | 1 | 6 | 29 |
GO:0032154 | cleavage furrow | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 3 | 30 |
GO:0006508 | proteolysis | 3.41e-02 | 1.00e+00 | 2.750 | 2 | 11 | 264 |
GO:0005829 | cytosol | 3.56e-02 | 1.00e+00 | 1.313 | 5 | 88 | 1787 |
GO:0021762 | substantia nigra development | 3.77e-02 | 1.00e+00 | 4.707 | 1 | 1 | 34 |
GO:0007254 | JNK cascade | 3.77e-02 | 1.00e+00 | 4.707 | 1 | 1 | 34 |
GO:0008565 | protein transporter activity | 3.87e-02 | 1.00e+00 | 4.665 | 1 | 2 | 35 |
GO:0050434 | positive regulation of viral transcription | 3.87e-02 | 1.00e+00 | 4.665 | 1 | 5 | 35 |
GO:0007266 | Rho protein signal transduction | 3.87e-02 | 1.00e+00 | 4.665 | 1 | 2 | 35 |
GO:0030334 | regulation of cell migration | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 2 | 36 |
GO:0030666 | endocytic vesicle membrane | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 1 | 36 |
GO:0006396 | RNA processing | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 6 | 40 |
GO:0032481 | positive regulation of type I interferon production | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 3 | 48 |
GO:0006366 | transcription from RNA polymerase II promoter | 5.43e-02 | 1.00e+00 | 2.380 | 2 | 23 | 341 |
GO:0006289 | nucleotide-excision repair | 5.81e-02 | 1.00e+00 | 4.066 | 1 | 6 | 53 |
GO:0045666 | positive regulation of neuron differentiation | 5.81e-02 | 1.00e+00 | 4.066 | 1 | 3 | 53 |
GO:0042826 | histone deacetylase binding | 6.35e-02 | 1.00e+00 | 3.936 | 1 | 5 | 58 |
GO:0071013 | catalytic step 2 spliceosome | 6.66e-02 | 1.00e+00 | 3.863 | 1 | 5 | 61 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 6.98e-02 | 1.00e+00 | 3.794 | 1 | 3 | 64 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 7.30e-02 | 1.00e+00 | 3.728 | 1 | 5 | 67 |
GO:0030308 | negative regulation of cell growth | 7.61e-02 | 1.00e+00 | 3.665 | 1 | 3 | 70 |
GO:0030496 | midbody | 7.93e-02 | 1.00e+00 | 3.604 | 1 | 6 | 73 |
GO:0042803 | protein homodimerization activity | 8.12e-02 | 1.00e+00 | 2.053 | 2 | 13 | 428 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 8.24e-02 | 1.00e+00 | 3.546 | 1 | 2 | 76 |
GO:0005938 | cell cortex | 8.34e-02 | 1.00e+00 | 3.527 | 1 | 6 | 77 |
GO:0030529 | ribonucleoprotein complex | 8.86e-02 | 1.00e+00 | 3.436 | 1 | 5 | 82 |
GO:0005215 | transporter activity | 8.86e-02 | 1.00e+00 | 3.436 | 1 | 5 | 82 |
GO:0048015 | phosphatidylinositol-mediated signaling | 8.97e-02 | 1.00e+00 | 3.419 | 1 | 2 | 83 |
GO:0030027 | lamellipodium | 9.48e-02 | 1.00e+00 | 3.335 | 1 | 3 | 88 |
GO:0006886 | intracellular protein transport | 9.59e-02 | 1.00e+00 | 3.318 | 1 | 2 | 89 |
GO:0030036 | actin cytoskeleton organization | 9.69e-02 | 1.00e+00 | 3.302 | 1 | 4 | 90 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.14e-01 | 1.00e+00 | 3.053 | 1 | 5 | 107 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.15e-01 | 1.00e+00 | 3.039 | 1 | 2 | 108 |
GO:0042981 | regulation of apoptotic process | 1.19e-01 | 1.00e+00 | 2.987 | 1 | 4 | 112 |
GO:0007049 | cell cycle | 1.22e-01 | 1.00e+00 | 2.948 | 1 | 8 | 115 |
GO:0003924 | GTPase activity | 1.26e-01 | 1.00e+00 | 2.899 | 1 | 7 | 119 |
GO:0006184 | GTP catabolic process | 1.37e-01 | 1.00e+00 | 2.772 | 1 | 7 | 130 |
GO:0030168 | platelet activation | 1.48e-01 | 1.00e+00 | 2.654 | 1 | 5 | 141 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.49e-01 | 1.00e+00 | 2.644 | 1 | 5 | 142 |
GO:0044212 | transcription regulatory region DNA binding | 1.50e-01 | 1.00e+00 | 2.634 | 1 | 13 | 143 |
GO:0005739 | mitochondrion | 1.67e-01 | 1.00e+00 | 1.430 | 2 | 32 | 659 |
GO:0007264 | small GTPase mediated signal transduction | 1.80e-01 | 1.00e+00 | 2.351 | 1 | 8 | 174 |
GO:0004842 | ubiquitin-protein transferase activity | 1.84e-01 | 1.00e+00 | 2.310 | 1 | 17 | 179 |
GO:0003713 | transcription coactivator activity | 1.89e-01 | 1.00e+00 | 2.270 | 1 | 21 | 184 |
GO:0016567 | protein ubiquitination | 1.93e-01 | 1.00e+00 | 2.239 | 1 | 14 | 188 |
GO:0005856 | cytoskeleton | 1.94e-01 | 1.00e+00 | 2.224 | 1 | 8 | 190 |
GO:0005743 | mitochondrial inner membrane | 2.01e-01 | 1.00e+00 | 2.172 | 1 | 9 | 197 |
GO:0005525 | GTP binding | 2.01e-01 | 1.00e+00 | 2.172 | 1 | 12 | 197 |
GO:0006281 | DNA repair | 2.06e-01 | 1.00e+00 | 2.129 | 1 | 24 | 203 |
GO:0008134 | transcription factor binding | 2.12e-01 | 1.00e+00 | 2.087 | 1 | 10 | 209 |
GO:0019899 | enzyme binding | 2.13e-01 | 1.00e+00 | 2.080 | 1 | 7 | 210 |
GO:0007268 | synaptic transmission | 2.16e-01 | 1.00e+00 | 2.053 | 1 | 7 | 214 |
GO:0003723 | RNA binding | 2.46e-01 | 1.00e+00 | 1.846 | 1 | 22 | 247 |
GO:0046982 | protein heterodimerization activity | 2.61e-01 | 1.00e+00 | 1.744 | 1 | 11 | 265 |
GO:0005524 | ATP binding | 2.66e-01 | 1.00e+00 | 0.993 | 2 | 37 | 892 |
GO:0008285 | negative regulation of cell proliferation | 2.71e-01 | 1.00e+00 | 1.680 | 1 | 11 | 277 |
GO:0005925 | focal adhesion | 2.76e-01 | 1.00e+00 | 1.654 | 1 | 14 | 282 |
GO:0070062 | extracellular vesicular exosome | 2.78e-01 | 1.00e+00 | 0.699 | 3 | 51 | 1641 |
GO:0009986 | cell surface | 2.83e-01 | 1.00e+00 | 1.609 | 1 | 5 | 291 |
GO:0005634 | nucleus | 2.87e-01 | 1.00e+00 | 0.451 | 5 | 158 | 3246 |
GO:0003677 | DNA binding | 2.90e-01 | 1.00e+00 | 0.907 | 2 | 52 | 947 |
GO:0005515 | protein binding | 2.98e-01 | 1.00e+00 | 0.369 | 6 | 198 | 4124 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.05e-01 | 1.00e+00 | 1.486 | 1 | 17 | 317 |
GO:0007596 | blood coagulation | 3.22e-01 | 1.00e+00 | 1.389 | 1 | 13 | 339 |
GO:0005737 | cytoplasm | 3.42e-01 | 1.00e+00 | 0.431 | 4 | 127 | 2633 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.52e-01 | 1.00e+00 | 1.236 | 1 | 21 | 377 |
GO:0016020 | membrane | 4.02e-01 | 1.00e+00 | 0.557 | 2 | 56 | 1207 |
GO:0045087 | innate immune response | 4.06e-01 | 1.00e+00 | 0.974 | 1 | 12 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.09e-01 | 1.00e+00 | 0.961 | 1 | 29 | 456 |
GO:0005887 | integral component of plasma membrane | 4.87e-01 | 1.00e+00 | 0.627 | 1 | 8 | 575 |
GO:0007165 | signal transduction | 5.13e-01 | 1.00e+00 | 0.523 | 1 | 24 | 618 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.28e-01 | 1.00e+00 | 0.463 | 1 | 29 | 644 |
GO:0006355 | regulation of transcription, DNA-templated | 5.67e-01 | 1.00e+00 | 0.312 | 1 | 31 | 715 |
GO:0044822 | poly(A) RNA binding | 6.09e-01 | 1.00e+00 | 0.152 | 1 | 45 | 799 |
GO:0005886 | plasma membrane | 6.24e-01 | 1.00e+00 | -0.007 | 2 | 46 | 1784 |
GO:0005730 | nucleolus | 7.69e-01 | 1.00e+00 | -0.455 | 1 | 74 | 1217 |